Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Non‐targeted hepatitis C virus screening in acute care healthcare settings in the Southern Appalachian region
by
Jones, Ian D., MD
, Adams, Sarah, MPH
, Potter, Rachel
, Quedado, Kimberly, PhD
, Moore, Daniel, MD, MBA
, Crowe, Jane, MSW
, Self, Wesley H., MD, MPH
, Parker, Diana
, Jenkins, Cathy A., MS
, Cave, Barbra, PhD, APRN
, Han, Jin H., MD
, Rose, Michelle
, Chastain, Cody A., MD
, Rubio, Marrieth G., MD
in
Antibodies
/ Brief Research Report
/ Departments
/ Emergency medical care
/ epidemiology
/ Hepatitis C
/ hepatitis c virus
/ Infections
/ Infectious Disease
/ injection drug use
/ Outpatient care facilities
/ Patients
/ preventive care
/ surviellance
/ viral hepatitis
2022
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Non‐targeted hepatitis C virus screening in acute care healthcare settings in the Southern Appalachian region
by
Jones, Ian D., MD
, Adams, Sarah, MPH
, Potter, Rachel
, Quedado, Kimberly, PhD
, Moore, Daniel, MD, MBA
, Crowe, Jane, MSW
, Self, Wesley H., MD, MPH
, Parker, Diana
, Jenkins, Cathy A., MS
, Cave, Barbra, PhD, APRN
, Han, Jin H., MD
, Rose, Michelle
, Chastain, Cody A., MD
, Rubio, Marrieth G., MD
in
Antibodies
/ Brief Research Report
/ Departments
/ Emergency medical care
/ epidemiology
/ Hepatitis C
/ hepatitis c virus
/ Infections
/ Infectious Disease
/ injection drug use
/ Outpatient care facilities
/ Patients
/ preventive care
/ surviellance
/ viral hepatitis
2022
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Non‐targeted hepatitis C virus screening in acute care healthcare settings in the Southern Appalachian region
by
Jones, Ian D., MD
, Adams, Sarah, MPH
, Potter, Rachel
, Quedado, Kimberly, PhD
, Moore, Daniel, MD, MBA
, Crowe, Jane, MSW
, Self, Wesley H., MD, MPH
, Parker, Diana
, Jenkins, Cathy A., MS
, Cave, Barbra, PhD, APRN
, Han, Jin H., MD
, Rose, Michelle
, Chastain, Cody A., MD
, Rubio, Marrieth G., MD
in
Antibodies
/ Brief Research Report
/ Departments
/ Emergency medical care
/ epidemiology
/ Hepatitis C
/ hepatitis c virus
/ Infections
/ Infectious Disease
/ injection drug use
/ Outpatient care facilities
/ Patients
/ preventive care
/ surviellance
/ viral hepatitis
2022
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Non‐targeted hepatitis C virus screening in acute care healthcare settings in the Southern Appalachian region
Journal Article
Non‐targeted hepatitis C virus screening in acute care healthcare settings in the Southern Appalachian region
2022
Request Book From Autostore
and Choose the Collection Method
Overview
AbstractObjectivesThe objective of this study was to evaluate the performance of non‐targeted hepatitis C virus (HCV) screening in emergency departments (EDs) and other healthcare settings in terms of patients identified with HCV infection and linked to HCV care. MethodsIn the Southern Appalachian region of the United States, we developed non‐targeted HCV screening and linkage‐to‐care programs in 10 institutions at different healthcare settings, including EDs, outpatient clinics, and inpatient units. Serum samples were tested for HCV antibodies, and if positive, reflexed to HCV ribonucleic acid (RNA) testing as a confirmatory test for active infection. Patients with positive RNA tests were contacted to link them to HCV care. ResultsBetween 2017 and 2019, among 195,152 patients screened for HCV infection, 16,529 (8.5%) were positive by antibody testing, 10,139 (5.2% of screened patients and 61.3% of patients positive by antibody test) were positive by RNA testing, and 5778 (3.0% of screened patients and 57.0% of patients positive by RNA test) were successfully linked to HCV care. Among 83,645 patients screened in EDs, 9060 (10.8%) were positive by HCV antibody, and 5243 (6.3%) were positive by RNA test. Among patients positive by RNA testing, linkage to care was lower for patients screened in the ED (44.1%) compared with outpatient clinics (67.6%) ( P < 0.01) and inpatient units (50.9%) ( P < 0.01). ConclusionsNon‐targeted HCV screening in acute care settings can identify large numbers of people with HCV infection. To optimize the utility of these screening programs, future work is needed to develop best practices that consistently link these patients to HCV care.
Publisher
John Wiley & Sons, Inc,John Wiley and Sons Inc,Elsevier
This website uses cookies to ensure you get the best experience on our website.